Who is sponsoring NCT05194852?

NCT05194852 is sponsored by Tanta University.

What drugs are being tested in NCT05194852?

Interventions in NCT05194852: ultrasound-guided posterior hydrodilatation, corticosteroid, saline, and local anesthetic, guided stretching and strengthening exercise program.

What condition does NCT05194852 study?

NCT05194852 studies Shoulder Capsulitis.

Is NCT05194852 still recruiting?

NCT05194852 is currently completed. Last updated 18 January 2022.

Last reviewed 2022-01-18 · How we verify

NCT05194852

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound-guided Anterior Hydrodilatation in Shoulder Adhesive Capsulitis

Completed NA Last updated 18 January 2022

What this trial tests

NA trial testing ultrasound-guided posterior hydrodilatation in Shoulder Capsulitis in 60 participants. Completed in 28 September 2018.

Timeline

2 January 2018

Primary endpoint
30 June 2018

28 September 2018

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	2 January 2018
Primary completion	30 June 2018
Estimated completion	28 September 2018
Sites	1 location across Egypt

Drugs / interventions tested

ultrasound-guided posterior hydrodilatation
corticosteroid, saline, and local anesthetic — full drug profile →
guided stretching and strengthening exercise program

Conditions studied

Shoulder Capsulitis — all drugs for Shoulder Capsulitis →

Sponsor

Tanta University

Who can join

Adults 35 to 60, any sex, with Shoulder Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective randomized controlled study among 60 consecutive adhesive capsulitis to compare between the ultrasound-guided anterior hydrodilatation in rotator interval and the posterior approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05194852 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 18 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing